MS methods to study macromolecule-ligand interaction: Applications in drug discovery

Area of Science:

• Biochemistry and Pharmacology
• Analytical Chemistry
• Drug Discovery and Development

Background:

• Drug action relies on interactions between small molecules (ligands) and biological targets (macromolecules).
• Mass spectrometry is a key technique for analyzing these macromolecule-ligand interactions in drug discovery.
• Its applications span biomarker screening, mechanism of action studies, and toxicity assessments.

Purpose of the Study:

• To review mass spectrometry methods for studying macromolecule-ligand interactions.
• To highlight applications in defining drug candidate structure-activity relationships (SAR).
• To discuss the role of mass spectrometry in understanding drug metabolism and toxicity.

Main Methods:

• Utilizing mass spectrometry for direct interrogation of macromolecule-ligand binding.
• Employing high-throughput mass spectrometry techniques for accelerated screening.
• Leveraging advanced instrumentation for high sensitivity and low false discovery rates.

Main Results:

• Mass spectrometry facilitates comprehensive analysis of drug-target interactions.
• Automated, high-throughput methods enhance efficiency in drug discovery pipelines.
• The technique is crucial for detailed SAR, mechanism of action, metabolism, and toxicity profiling.

Conclusions:

• Mass spectrometry is indispensable for modern drug discovery and development.
• Its adaptability supports diverse applications from initial screening to late-stage evaluation.
• Advancements in mass spectrometry drive the identification and optimization of effective drug candidates.